Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -32.73% is 28% above its 5-year average of -45.46%, near the high end of its 5-year range (-196.73%–-18.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 47.58% above its 12-month average of -62.43%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -32.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-32.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-62.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-77.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-45.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+47.58%
CURRENT VS 3Y AVG
+57.97%
CURRENT VS 5Y AVG
+28.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
+1.97%
vs the sector median at left
Immuneering Corporation
Market Cap
$144.48M
Return on Invested Capital (ROIC)
-32.73%
TTM Avg
-62.43%
3Y Avg
-77.87%
5Y Avg
-45.46%
Market Cap
$144.00M
Return on Invested Capital (ROIC)
-134.15%
TTM Avg
-47.87%
3Y Avg
-96.96%
5Y Avg
-96.99%
Market Cap
$142.60M
Return on Invested Capital (ROIC)
-61.13%
TTM Avg
-65.92%
3Y Avg
-49.38%
5Y Avg
-37.06%
Market Cap
$150.23M
Return on Invested Capital (ROIC)
-118.67%
TTM Avg
-87.91%
3Y Avg
-55.09%
5Y Avg
-41.64%
Market Cap
$147.13M
Return on Invested Capital (ROIC)
-223.90%
TTM Avg
-825.42%
3Y Avg
-606.12%
5Y Avg
-416.73%
Market Cap
$147.97M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$142.15M
Return on Invested Capital (ROIC)
-7.01%
TTM Avg
-1.96%
3Y Avg
-0.91%
5Y Avg
1.75%
Market Cap
$139.73M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$139.63M
Return on Invested Capital (ROIC)
-50.04%
TTM Avg
-28.33%
3Y Avg
-324.90%
5Y Avg
-237.35%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $144.48M | -32.73% | -62.43% | -77.87% | -45.46% |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.00M | -134.15% | -47.87% | -96.96% | -96.99% |
| Nyxoah S.A. (NYXH)vs › | $142.60M | -61.13% | -65.92% | -49.38% | -37.06% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.23M | -118.67% | -87.91% | -55.09% | -41.64% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.13M | -223.90% | -825.42% | -606.12% | -416.73% |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -143.97% | -52.39% | -55.03% | -91.26% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $142.15M | -7.01% | -1.96% | -0.91% | 1.75% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -10.85% | -101.00% | -120.85% | -96.47% |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | -50.04% | -28.33% | -324.90% | -237.35% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | -165.56% | -176.54% | -127.81% | -112.12% |
ROIC
-32.7%
ROE
-30.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -32.73% |
| 2026-03-31 | -28.23% |
| 2025-12-31 | -26.76% |
| 2025-09-30 | -27.72% |
| 2025-06-30 | -196.73% |
| 2025-03-31 | -140.94% |
| 2024-12-31 | -141.72% |
| 2024-09-30 | -100.29% |
| 2024-06-30 | -86.01% |
| 2024-03-31 | -71.32% |
| 2023-12-31 | -61.66% |
| 2023-09-30 | -51.82% |
| 2023-06-30 | -46.36% |
| 2023-03-31 | -52.36% |
| 2022-12-31 | -45.27% |
| 2022-09-30 | -38.66% |
| 2022-06-30 | -31.99% |
| 2022-03-31 | -27.27% |
| 2021-12-31 | -21.04% |
| 2021-09-30 | -18.02% |
| 2021-06-30 | -50.74% |
| 2021-03-31 | -66.71% |
| 2020-12-31 | -47.23% |
